Nuvalent, Inc.

Nuvalent, Inc.

生物技术研究

Cambridge,Massachusetts 5,976 位关注者

#PreciselyTargetedTherapies for patients with cancer

关于我们

Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.

网站
https://www.nuvalent.com/
所属行业
生物技术研究
规模
11-50 人
总部
Cambridge,Massachusetts
类型
私人持股
创立
2017

地点

  • 主要

    One Broadway 14th Floor

    US,Massachusetts,Cambridge,02142

    获取路线

Nuvalent, Inc.员工

动态

相似主页

查看职位

融资

Nuvalent, Inc. 共 5 轮

上一轮

上市后股权

US$575,000,000.00

Crunchbase 上查看更多信息